The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takada, Y.
Right arrow Articles by Aggarwal, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takada, Y.
Right arrow Articles by Aggarwal, B. B.
The Journal of Immunology, 2004, 173: 1066-1077.
Copyright © 2004 by The American Association of Immunologists

TNF Activates Syk Protein Tyrosine Kinase Leading to TNF-Induced MAPK Activation, NF-{kappa}B Activation, and Apoptosis1

Yasunari Takada and Bharat B. Aggarwal2

Cytokine Research Laboratory, Department of Bioimmunotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030

Spleen tyrosine kinase (Syk), a nonreceptor protein kinase initially found to be expressed only in hemopoietic cells, has now been shown to be expressed in nonhemopoietic cells and to mediate signaling of various cytokines. Whether Syk plays any role in TNF signaling was investigated. Treatment of Jurkat T cells with TNF activated Syk kinase but not ZAP70, another member of Syk kinase family, and the optimum activation occurred at 10 s and with 1 nM TNF. TNF also activated Syk in myeloid and epithelial cells. TNF-induced Syk activation was abolished by piceatannol (Syk-selective inhibitor), which led to the suppression of TNF-induced activation of c- JNK, p38 MAPK, and p44/p42 MAPK. Jurkat cells that did not express Syk (JCaM1, JCaM1/lck) showed lack of TNF-induced Syk, JNK, p38 MAPK, and p44/p42 MAPK activation, as well as TNF-induced I{kappa}B{alpha} phosphorylation, I{kappa}B{alpha} degradation, and NF-{kappa}B activation. TNF-induced NF-{kappa}B activation was enhanced by overexpression of Syk by Syk-cDNA and suppressed when Syk expression was down-regulated by expression of Syk-small interfering RNA (siRNA-Syk). The apoptotic effects of TNF were reduced by up-regulation of NF-{kappa}B by Syk-cDNA, and enhanced by down-regulation of NF-{kappa}B by siRNA-Syk. Immunoprecipitation of cells with Syk Abs showed TNF-dependent association of Syk with both TNFR1 and TNFR2; this association was enhanced by up-regulation of Syk expression with Syk-cDNA and suppressed by down-regulation of Syk using siRNA-Syk. Overall, our results demonstrate that Syk activation plays an essential role in TNF-induced activation of JNK, p38 MAPK, p44/p42 MAPK, NF-{kappa}B, and apoptosis.




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Pincheira, A. F. Castro, O. N. Ozes, P. S. Idumalla, and D. B. Donner
Type 1 TNF Receptor Forms a Complex with and Uses Jak2 and c-Src to Selectively Engage Signaling Pathways That Regulate Transcription Factor Activity
J. Immunol., July 15, 2008; 181(2): 1288 - 1298.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Bijli, F. Fazal, M. Minhajuddin, and A. Rahman
Activation of Syk by Protein Kinase C-{delta} Regulates Thrombin-induced Intercellular Adhesion Molecule-1 Expression in Endothelial Cells via Tyrosine Phosphorylation of RelA/p65
J. Biol. Chem., May 23, 2008; 283(21): 14674 - 14684.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. A. Yaghini, F. Li, and K. U. Malik
Expression and Mechanism of Spleen Tyrosine Kinase Activation by Angiotensin II and Its Implication in Protein Synthesis in Rat Vascular Smooth Muscle Cells
J. Biol. Chem., June 8, 2007; 282(23): 16878 - 16890.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
M. Ulanova, S. Asfaha, G. Stenton, A. Lint, D. Gilbertson, A. Schreiber, and D. Befus
Involvement of Syk protein tyrosine kinase in LPS-induced responses in macrophages
Innate Immunity, April 1, 2007; 13(2): 117 - 125.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
C.-K. Lee, H. M. Lee, H. J. Kim, H.-J. Park, K.-J. Won, H. Y. Roh, W. S. Choi, B. H. Jeon, T.-K. Park, and B. Kim
Syk contributes to PDGF-BB-mediated migration of rat aortic smooth muscle cells via MAPK pathways
Cardiovasc Res, April 1, 2007; 74(1): 159 - 168.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Gururajan, T. Dasu, S. Shahidain, C. D. Jennings, D. A. Robertson, V. M. Rangnekar, and S. Bondada
Spleen Tyrosine Kinase (Syk), a Novel Target of Curcumin, Is Required for B Lymphoma Growth
J. Immunol., January 1, 2007; 178(1): 111 - 121.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. S. Ahn, G. Sethi, and B. B. Aggarwal
Embelin, an Inhibitor of X Chromosome-Linked Inhibitor-of-Apoptosis Protein, Blocks Nuclear Factor-{kappa}B (NF-{kappa}B) Signaling Pathway Leading to Suppression of NF-{kappa}B-Regulated Antiapoptotic and Metastatic Gene Products
Mol. Pharmacol., January 1, 2007; 71(1): 209 - 219.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Schymeinsky, A. Sindrilaru, D. Frommhold, M. Sperandio, R. Gerstl, C. Then, A. Mocsai, K. Scharffetter-Kochanek, and B. Walzog
The Vav binding site of the non-receptor tyrosine kinase Syk at Tyr 348 is critical for beta2 integrin (CD11/CD18)-mediated neutrophil migration
Blood, December 1, 2006; 108(12): 3919 - 3927.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Wang, C. Lau, S. Wiehler, A. Pow, T. Mazzulli, C. Gutierrez, D. Proud, and C.-W. Chow
Syk Is Downstream of Intercellular Adhesion Molecule-1 and Mediates Human Rhinovirus Activation of p38 MAPK in Airway Epithelial Cells
J. Immunol., November 15, 2006; 177(10): 6859 - 6870.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Gururajan, C. D. Jennings, and S. Bondada
Cutting Edge: Constitutive B Cell Receptor Signaling Is Critical for Basal Growth of B Lymphoma
J. Immunol., May 15, 2006; 176(10): 5715 - 5719.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H.-S. Cha, D. L. Boyle, T. Inoue, R. Schoot, P. P. Tak, P. Pine, and G. S. Firestein
A Novel Spleen Tyrosine Kinase Inhibitor Blocks c-Jun N-Terminal Kinase-Mediated Gene Expression in Synoviocytes
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 571 - 578.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. G. Eliopoulos, S. Das, and P. N. Tsichlis
The Tyrosine Kinase Syk Regulates TPL2 Activation Signals
J. Biol. Chem., January 20, 2006; 281(3): 1371 - 1380.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
K. S. AHN and B. B. AGGARWAL
Transcription Factor NF-{kappa}B: A Sensor for Smoke and Stress Signals
Ann. N.Y. Acad. Sci., November 1, 2005; 1056(1): 218 - 233.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.